The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $1,521.95 and a period of performance through April 1, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $6,557.58 and a period of performance through April 4, 2024. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $16,047.84 and an ultimate completion date of March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,496 units of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a ceiling value of $5,480.75 and a period of performance through April 11, 2024. This delivery order is likely issued under AmerisourceBergen Drug Corp's existing indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The $3,887.63 contract has an ultimate completion date of April 1, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a potential value of $8,675.27 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. This delivery order is issued under Amerisourcebergen's...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a ceiling value of $4,565.85 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,486.91 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a period of performance ending on March 13, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a potential value of $2,158.21 and a completion date of February 21, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The contract has a ceiling value of $3,417.60 and a period of performance through April 2, 2024. This award is associated with a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a...